WORK Medical Technology Group LTD
WORK Medical Technology Group LTD is a medical device company with operating subsidiaries in China that develops and manufactures Class I and II medical devices and sells disposable medical products. Its portfolio includes masks and other medical consumables, and the group also markets anesthesia and respiratory consumables through its medical device line.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueSelf-manufactured medical devices, mainly anesthesia and respiratory consumables.
Disposable and customized mask products sold through the company’s China operations.
Small-scale trading of products outside the core medical device portfolio.
Minor residual sales not classified within the main product lines.
Products
Reported · share of revenue- Medical Devices Other Than Masks92.7 %
- Masks6.5 %
- Commodity Trading0.6 %
- Others Revenue Product0.2 %
Source: 20-F FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells primarily to distributor customers and direct end users, with credit terms varying by customer relationship and creditworthiness. Its products serve medical channels that need disposable consumables, masks, and anesthesia or respiratory supplies, with sales in China and selected overseas markets.
Buy medical devices and consumables for resale into local medical supply channels.
Purchase products directly for use in care delivery or operations.
Hospitals and clinics buy anesthesia and respiratory consumables for routine use.
International customers purchase approved products through export channels.
Strategy
The company is building a more direct international platform by establishing a U.S. subsidiary to support supply-chain management, customer engagement, and regulatory execution. Its broader strategy is to extend its medical-device portfolio beyond China while using FDA-registered products and existing manufacturing capabilities to support export growth.
A direct U.S. presence can improve customer access, market development, and operational control.
Diversifying beyond China can broaden the addressable market and reduce dependence on one geography.
FDA registrations and compliance capabilities are essential to selling in regulated medical markets.
Geography
WORK Medical’s core operating base is in China, where it sells across 34 provincial-level administrative regions. It also sells overseas and has registered products with the U.S. FDA, supporting access to the U.S. market and broader international distribution.
Risks
The business depends on regulatory approvals, product quality, and the ability to collect receivables from distributors and end users. It also faces execution risk in expanding outside China, where local market access, supply-chain coordination, and compliance requirements can affect growth and operating stability.
- Receivable collectabilityImpact: HighLikelihood: High
The company grants 30 to 180 days of credit, increasing exposure to delayed payment or default.
Exposure: Accounts receivable and contract assets
- Product quality and recallsImpact: HighLikelihood: Medium
Medical devices and consumables are subject to quality objections and third-party testing.
Exposure: Manufacturing and sales of disposable medical devices
- Regulatory and market accessImpact: HighLikelihood: Medium
Medical device sales depend on registrations, approvals, and ongoing compliance in each market.
Exposure - Geographic concentrationImpact: MediumLikelihood: High
Most revenue is still derived from China, leaving the business exposed to local demand and policy changes.
Exposure: China domestic market
- Supplier disruptionImpact: MediumLikelihood: Medium
The company uses advance payments for raw materials and trading products, creating dependency on supplier performance.
Exposure: Raw materials and trading inputs
Accounting
Judgemental itemsSales are recognized when performance obligations are satisfied, which depends on shipment, acceptance, and objection periods.
Impact: Can shift revenue between periods
Customers are granted 30 to 180 days of credit, requiring estimates for uncollectible accounts.
Impact: Affects accounts receivable and bad-debt expense
Prepayments for raw materials and trading products must be tested for recoverability if suppliers weaken.
Impact: Can create write-downs or expense recognition
Similar listed companies
Publicly listed companies with a comparable business focus.
Akso Health Group
AHG · Services-Business Services, NEC
Akso Health Group is a U.S.-incorporated holding company with operating subsidiaries in the United States and China that sell medical devices and offer healthcare-related services.
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
Alpha Pro Tech, Ltd
APT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Medinotec Inc.
MDNC · Surgical & Medical Instruments & Apparatus
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Meihua International Medical Technologies Co., Ltd.
MHUAF · Surgical & Medical Instruments & Apparatus
Last updated: 28/09/2026